Activating CSF2RB Mutations Contribute to the Leukemic Transformation from TAM to ML-DS by Labuhn, M, Perkins, K, El Kathib, M, Taub, J, Heckl, D, Vyas, P, Klusmann, J

Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells by Hartenian, E., Shi, X., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., Shalem, Ophir, Sanjana, Neville E, Scott, David Arthur, Zhang, Feng

Get full text
Get full text
Get full text

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome by Labuhn, M, Perkins, K, Papaemmanuil, E, Garnett, C, Matzk, S, Amstislavskiy, V, Metzner, M, Kennedy, A, Scheer, C, Yoshida, K, Schwarzer, A, Crispino, J, Taub, J, Weiss, M, Ito, E, Ogawa, S, Reinhardt, D, Yaspo, M, Campbell, P, Heckl, D, Klusmann, J, Vyas, P

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome by Labuhn, M, Perkins, K, Matzk, S, Varghese, L, Garnett, C, Papaemmanuil, E, Metzner, M, Kennedy, A, Amstislavskiy, V, Risch, T, Bhayadia, R, Samulowski, D, Hernandez, D, Stoilova, B, Iotchkova, V, Oppermann, U, Scheer, C, Yoshida, K, Schwarzer, A, Taub, J, Crispino, J, Weiss, M, Hayashi, A, Taga, T, Ito, E, Ogawa, S, Reinhardt, D, Yaspo, M, Campbell, P, Roberts, I, Constantinescu, S, Vyas, P, Heckl, D, Klusmann, J